Episode 102: U.S. Food and Drug Administration Recognizes Oncology Nursing Month

Richard Pazdur, MD, director of the U.S. Food and Drug Administration’s Oncology Center of Excellence (OCE), joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss oncology nurses’ contributions to cancer care, OCE’s initiatives, and the COVID-19 coronavirus pandemic’s implications for oncology drug approvals.  

Music Credit: "Fireflies and Stardust" by Kevin MacLeod

Licensed under Creative Commons by Attribution 3.0   

Episode Notes 

Check out these resources from today’s episode: 

• FDA new drug approval announcements on ONS Voice
• Richard Pazdur’s biography
• Oncology Center of Excellence
• FDA Guidance on Conduct of Clinical Trials During COVID-19
• FDA Community Outreach and Education Programs
• Project Facilitate
• Project Orbis
• Register for the Mosaic of Oncology Nursing webinar on May 19 from 2–3 pm EST.
• COVID-19 articleson ONS Voice 
• ONS Information Regarding the Coronavirus (COVID-19)
• ONS Interim PPE Guidelines During the COVID-19 Pandemic